MEP25508A - Antipsychotic cyclic n-aralkyl amines - Google Patents
Antipsychotic cyclic n-aralkyl aminesInfo
- Publication number
- MEP25508A MEP25508A MEP-255/08A MEP25508A MEP25508A ME P25508 A MEP25508 A ME P25508A ME P25508 A MEP25508 A ME P25508A ME P25508 A MEP25508 A ME P25508A
- Authority
- ME
- Montenegro
- Prior art keywords
- chlorine
- hydrogen
- compounds
- fluorine atom
- aralkyl amines
- Prior art date
Links
- 230000000561 anti-psychotic effect Effects 0.000 title 1
- 125000004122 cyclic group Chemical group 0.000 title 1
- -1 bicyclo [3.2.1] octanyl Chemical group 0.000 abstract 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 239000000460 chlorine Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052731 fluorine Chemical group 0.000 abstract 2
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 125000004487 4-tetrahydropyranyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000004342 dicyclopropylmethyl group Chemical group [H]C1([H])C([H])([H])C1([H])C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9908532A FR2795724B1 (fr) | 1999-07-02 | 1999-07-02 | Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
| PCT/FR2000/001790 WO2001002380A1 (fr) | 1999-07-02 | 2000-06-27 | N-aralkyl amines cycliques antipsychotiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP25508A true MEP25508A (en) | 2010-06-10 |
Family
ID=9547628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-255/08A MEP25508A (en) | 1999-07-02 | 2000-06-27 | Antipsychotic cyclic n-aralkyl amines |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6908914B1 (de) |
| EP (1) | EP1196403B1 (de) |
| JP (1) | JP4931309B2 (de) |
| KR (1) | KR100760446B1 (de) |
| CN (1) | CN1156462C (de) |
| AR (1) | AR029374A1 (de) |
| AT (1) | ATE309231T1 (de) |
| AU (1) | AU778299B2 (de) |
| BG (1) | BG65209B1 (de) |
| BR (1) | BR0012463B1 (de) |
| CA (1) | CA2376691C (de) |
| CO (1) | CO5021196A1 (de) |
| CZ (1) | CZ300936B6 (de) |
| DE (1) | DE60023898T2 (de) |
| DK (1) | DK1196403T3 (de) |
| EA (1) | EA004048B1 (de) |
| ES (1) | ES2250160T3 (de) |
| FR (1) | FR2795724B1 (de) |
| HK (1) | HK1043122A1 (de) |
| HR (1) | HRP20010949B1 (de) |
| HU (1) | HU228983B1 (de) |
| IL (2) | IL147069A0 (de) |
| ME (1) | MEP25508A (de) |
| MX (1) | MXPA01013207A (de) |
| NO (1) | NO322230B1 (de) |
| NZ (1) | NZ516342A (de) |
| RS (1) | RS50266B (de) |
| TW (1) | TWI285640B (de) |
| UA (1) | UA71009C2 (de) |
| WO (1) | WO2001002380A1 (de) |
| ZA (1) | ZA200200018B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2266618T3 (es) * | 2001-08-23 | 2007-03-01 | Bayer Cropscience S.A. | Propargilaminas substituidas. |
| WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| EP2314289A1 (de) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba-rezeptor-vermittelte modulation von neurogenese |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| EP2021000A2 (de) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenese mittels angiotensin-modulation |
| US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE790971A (fr) * | 1971-11-09 | 1973-05-07 | Janssen Pharmaceutica Nv | Metode ter voorkoming van patologische reakties die de funktie van het komplement vereisen |
| JPS504086A (de) * | 1973-01-18 | 1975-01-16 | ||
| US4104383A (en) * | 1973-11-02 | 1978-08-01 | C M Industries | Derivatives of phenylpropenylamine |
| GB1475314A (en) * | 1973-11-02 | 1977-06-01 | Cm Ind | Phenyl-propylamine derivatives |
| US4912222A (en) * | 1988-06-17 | 1990-03-27 | Fisons Corporation | Antihistamines related to cyproheptadine |
| US4855462A (en) * | 1988-06-17 | 1989-08-08 | Pennwalt Corporation | Antihistamines |
| EP0347123A3 (de) * | 1988-06-17 | 1991-07-03 | Fisons Corporation | Dibenzo-cycloheptenyl-, -cycloheptyl- und -oxepinylamine mit antihistaminischer Aktivität |
| FR2663328B1 (fr) | 1990-06-14 | 1994-08-05 | Sanofi Sa | Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant. |
| AU676993B2 (en) * | 1991-06-27 | 1997-04-10 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
| JP3199405B2 (ja) * | 1991-08-30 | 2001-08-20 | 生化学工業株式会社 | 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法 |
| US5486517A (en) * | 1994-05-10 | 1996-01-23 | Warner-Lambert Company | Benzimidazoles and imidazopyridines as central nervous system agents |
| FR2751645B1 (fr) * | 1996-07-29 | 1998-12-24 | Sanofi Sa | Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales |
| IL131756A0 (en) * | 1997-03-18 | 2001-03-19 | Smithkline Beecham Plc | Substituted isoquinoline derivatives and their use as anticonvulsants |
-
1999
- 1999-07-02 FR FR9908532A patent/FR2795724B1/fr not_active Expired - Fee Related
-
2000
- 2000-06-27 EA EA200101209A patent/EA004048B1/ru not_active IP Right Cessation
- 2000-06-27 MX MXPA01013207A patent/MXPA01013207A/es active IP Right Grant
- 2000-06-27 DK DK00946022T patent/DK1196403T3/da active
- 2000-06-27 CZ CZ20014697A patent/CZ300936B6/cs not_active IP Right Cessation
- 2000-06-27 CA CA002376691A patent/CA2376691C/en not_active Expired - Fee Related
- 2000-06-27 US US10/019,205 patent/US6908914B1/en not_active Expired - Lifetime
- 2000-06-27 EP EP00946022A patent/EP1196403B1/de not_active Expired - Lifetime
- 2000-06-27 UA UA2001128823A patent/UA71009C2/uk unknown
- 2000-06-27 NZ NZ516342A patent/NZ516342A/en not_active IP Right Cessation
- 2000-06-27 JP JP2001507818A patent/JP4931309B2/ja not_active Expired - Fee Related
- 2000-06-27 AT AT00946022T patent/ATE309231T1/de active
- 2000-06-27 BR BRPI0012463-0A patent/BR0012463B1/pt not_active IP Right Cessation
- 2000-06-27 TW TW089112618A patent/TWI285640B/zh not_active IP Right Cessation
- 2000-06-27 HR HR20010949A patent/HRP20010949B1/xx not_active IP Right Cessation
- 2000-06-27 IL IL14706900A patent/IL147069A0/xx active IP Right Grant
- 2000-06-27 CN CNB008111413A patent/CN1156462C/zh not_active Expired - Fee Related
- 2000-06-27 ES ES00946022T patent/ES2250160T3/es not_active Expired - Lifetime
- 2000-06-27 HK HK02104681.4A patent/HK1043122A1/zh unknown
- 2000-06-27 KR KR1020017016966A patent/KR100760446B1/ko not_active Expired - Fee Related
- 2000-06-27 AU AU59924/00A patent/AU778299B2/en not_active Ceased
- 2000-06-27 ME MEP-255/08A patent/MEP25508A/xx unknown
- 2000-06-27 RS YU91101A patent/RS50266B/sr unknown
- 2000-06-27 HU HU0202200A patent/HU228983B1/hu not_active IP Right Cessation
- 2000-06-27 DE DE60023898T patent/DE60023898T2/de not_active Expired - Lifetime
- 2000-06-27 WO PCT/FR2000/001790 patent/WO2001002380A1/fr not_active Ceased
- 2000-06-28 CO CO00048530A patent/CO5021196A1/es unknown
- 2000-06-30 AR ARP000103334A patent/AR029374A1/es active IP Right Grant
-
2001
- 2001-12-12 IL IL147069A patent/IL147069A/en not_active IP Right Cessation
- 2001-12-20 BG BG106255A patent/BG65209B1/bg unknown
- 2001-12-27 NO NO20016392A patent/NO322230B1/no not_active IP Right Cessation
-
2002
- 2002-01-02 ZA ZA200200018A patent/ZA200200018B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1468990A4 (de) | Piperazinderivat | |
| MEP61208A (bs) | Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma | |
| ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
| NO20073371L (no) | TNF-alfa-produksjonsinhibitorer | |
| ATE297910T1 (de) | Retinoid x rezeptormodulatoren | |
| DE69903976D1 (de) | Heteroaryl-zyklische acetale | |
| EP1679069A4 (de) | Neues piperidinderivat | |
| MEP12608A (en) | Derivatives of n-[phenyl (pyrrolidine-2-yl) methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics | |
| CO5611152A2 (es) | Compuestos derivados piperidina caracterizados por ser antagonistas del receptor de las taquicininas, especialmente del receptor nk1 y composiciones farmaceuticas que los contienen | |
| YU91101A (sh) | Antipsihoticni ciklicni n-aralkil amini | |
| ATE538780T1 (de) | Medizinische zusammensetzung, enthaltend ein hmg- coa reduktase inhibitor und ein aminoalkohol derivat, als immunsuppressivum | |
| HRP20070529T3 (hr) | Derivati imidazola kao antagonisti receptora glutamata | |
| WO2002024623A3 (en) | Novel alkanoic acid derivatives | |
| TW200745153A (en) | Trehalose compound and pharmaceutical comprising the compound | |
| MXPA04002569A (es) | H6,7-dihidro-5h-pirazolo[1,2-a]pirazol-1-onas espirociclicas que controlan citocinas inflamatorias. | |
| DE60130766D1 (de) | Serotoninwiederaufnahme-inhibitoren | |
| WO2003035610A1 (en) | Sulfonamide derivative having mmp inhibitory activity | |
| TW200505446A (en) | Inhibitor of cox | |
| CO4980898A1 (es) | Derivados del ciclohexanodiol | |
| WO2005061475A3 (en) | Ornithine derivatives as prostaglandin e2 agonists or antagonists | |
| ATE291928T1 (de) | Oberflächenaktive verbindungen | |
| YU52498A (sh) | UPOTREBA 2-ARILBENZO (b) TIOFENA ZA DOBIJANJE LEKA | |
| HRP20020440B1 (en) | 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof | |
| EP1721906A4 (de) | 3-pyridiniummethylcephemverbindung | |
| HRP20080363T3 (hr) | Piridin-4-il-etinil-imidazoli i pirazoli kao antagonisti mglu5 receptora |